Clinical Trials Directory

Trials / Completed

CompletedNCT03218293

Thrombolysis and RIPC in Acute Ischemic Stroke

The Recovery of Nerve Function Deficient of Combined Intravenous Thrombolysis and Remote Ischemic Post-conditioning in Acute Ischemic Stroke.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
68 (actual)
Sponsor
First Affiliated Hospital Xi'an Jiaotong University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Remote ischemic postconditioning (RIPC) is suggested to protect the cerebral cell against ischemia in various settings. However, the effect of RIPC in patients with acute ischemic stroke who undergo thrombolysis has yet to be examined. In this single-center, randomized controlled trial, we examined the effect of RIPC on the resolution of nerve function deficient in response to thrombolysis. Patients in the RIPC group had five cycles of 5-min cuff inflation followed by 3-min deflation to the bilateral upper arm after thrombolysis. The primary endpoint was the recovery of nerve function deficient assessed by National Institutes of Health Stroke Scale(NIHSS), Activities of Daily Living(ADL), Modified Rankin Scale(mRS), CT cerebral perfusion imaging (CTP) and CT angiography(CTA). Secondary endpoints included the following: angiogenesis assessed by the level of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF).

Conditions

Interventions

TypeNameDescription
DEVICERIPC device (IPC-906X)Patients in the RIPC group had five cycles of 5-min cuff inflation followed by 3-min deflation to the bilateral upper arm after thrombolysis.

Timeline

Start date
2017-08-01
Primary completion
2020-10-31
Completion
2020-10-31
First posted
2017-07-14
Last updated
2021-08-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03218293. Inclusion in this directory is not an endorsement.